InvestorsHub Logo
Followers 79
Posts 24450
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Monday, 09/11/2017 9:07:05 AM

Monday, September 11, 2017 9:07:05 AM

Post# of 27354
MRNS - 3.12 Pre-market now at 4.46/4.47

Marinus Announces Successful Clinical Trial Results and Declares CDKL5 Disorder Its Lead Pediatric Orphan Epilepsy Program for Ganaxolone



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.